MEMPHASYS LIMITED. - Announcements

Market Cap $13.00M Add to my watchlist

Memphasys Limited is an Australia-based reproductive biotechnology company. The Company... Memphasys Limited is an Australia-based reproductive biotechnology company. The Company is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals. The Company's product pipeline includes Felix, RoXsta, and AI-Port. Its advanced product, the Felix System, is a patented automated device for quickly and gently separating sperm from a semen sample for use in ART procedures. The Felix device consists of two main components: a console, which supplies electrical power, and a sterile disposable cartridge for sperm isolation and selection. RoXsta is an in-vitro diagnostic device that assesses semen and other bodily fluids for oxidative stress load. RoXsta also has an application as part of a suite of products that can support the animal industry. AI-Port has been developed for the purpose of maintaining the viability of livestock semen for up to seven days at a temperature range of 22 - 25 degrees Celsius.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

MEM	Appendix 3Y and Form 604		30/12/13	Share
MEM	PrIME receives Xeraya Board conditional approval for Funding	PRICE SENSITIVE	24/12/13	Share
MEM	Company Secretary Change		19/12/13	Share
MEM	NuSep Board Appointment		02/12/13	Share
MEM	NuSep Board Changes		29/11/13	Share
MEM	NuSep Results of AGM		29/11/13	Share
MEM	NuSep 2013 AGM Presentation		29/11/13	Share
MEM	Appendix 3Y and Form 604		27/11/13	Share
MEM	Annual Report		31/10/13	Share
MEM	Notice of Annual General Meeting as mailed to Shareholders		30/10/13	Share
MEM	Notice of Annual General Meeting/Proxy Form		30/10/13	Share
MEM	Board Changes		29/10/13	Share
MEM	PrIME signs Non Binding Funding Term Sheet	PRICE SENSITIVE	29/10/13	Share
MEM	NuSep Receives $1.6m R&D Tax Refund	PRICE SENSITIVE	08/10/13	Share
MEM	Annual Financial Report 30 June 2013		01/10/13	Share
MEM	Appendix 3B		16/09/13	Share
MEM	NuSep Presents at Bioplasma Conference		06/09/13	Share
MEM	Change in substantial holding x 2		30/08/13	Share
MEM	NuSep announces 30 June 2013 Full Year Results	PRICE SENSITIVE	30/08/13	Share
MEM	Increase in Director Holdings		29/08/13	Share
MEM	NuSep Restatement of Prior Period Accounts		29/08/13	Share
MEM	NuSep Raises $1.2m under SPP		26/08/13	Share
MEM	NuSep lodges $1.6m R&D Tax Refund	PRICE SENSITIVE	23/08/13	Share
MEM	Relodgement of Initial Substantial Shareholder		21/08/13	Share
MEM	Becoming a substantial holder		21/08/13	Share
MEM	NuSep 2013 SPP Closes		20/08/13	Share
MEM	Update on Settlement for the Acquisition of Singapore cGMP F		19/08/13	Share
MEM	NuSep Investor Presentation - SPP		08/08/13	Share
MEM	NuSep Shareholder Newsletter		07/08/13	Share
MEM	NuSep SPP Update & Investor Meetings		02/08/13	Share
MEM	Update on PrIME LOI Funding	PRICE SENSITIVE	29/07/13	Share
MEM	NuSep Share Purchase Plan 2013		23/07/13	Share
MEM	Section 708A SPP Cleansing Statement		23/07/13	Share
MEM	Funding Update & SPP Announcement	PRICE SENSITIVE	22/07/13	Share
MEM	Initial Substantial Shareholder		17/07/13	Share
MEM	Research Report on NuSep		10/07/13	Share
MEM	NuSep Investor Presentation		10/07/13	Share
MEM	NuSep Announces Long Term Debt Management	PRICE SENSITIVE	09/07/13	Share
MEM	Change of Address & Registered Office		05/07/13	Share
MEM	NuSep - New Headquarters		24/06/13	Share
MEM	PrIME Receives Plasma Importation License	PRICE SENSITIVE	11/06/13	Share
MEM	NuSep Signs LOI to Fund PrIME	PRICE SENSITIVE	03/06/13	Share
MEM	Company Secretary Update		03/06/13	Share
MEM	First PrIME Franchise Proposal	PRICE SENSITIVE	30/05/13	Share
MEM	Dengue Diagnostic & Therapeutic - New Application of PrIME	PRICE SENSITIVE	23/05/13	Share
MEM	NuSep Appoints KPMG as Company Auditor		21/05/13	Share
MEM	NuSep Update	PRICE SENSITIVE	20/05/13	Share
MEM	PrIME Update	PRICE SENSITIVE	15/05/13	Share
MEM	NSP Cleansing Notice		08/05/13	Share
MEM	Resignation of Auditor		01/05/13	Share
MEM	NuSep Singapore PrIME Fundraising and Appendix 3B	PRICE SENSITIVE	01/05/13	Share
MEM	Divestiture of non-core ProteoIQ software		15/03/13	Share
MEM	Reinstatement to Official Quotation	PRICE SENSITIVE	01/03/13	Share
MEM	NuSep Half Year Report & Accounts	PRICE SENSITIVE	01/03/13	Share
AEJ +PDF KFG MCH MEM HYD QST SAP YOW	Suspension from Official Quotation	PRICE SENSITIVE	01/03/13	Share
MEM	Appointment of New Company Secretary		15/02/13	Share
MEM	Updated NuSep Charters		25/01/13	Share
MEM	Ceasing to be a substantial holder		24/01/13	Share
MEM	Becoming a substantial holder		24/01/13	Share
MEM	NuSep divests non Core ProteoIQ software	PRICE SENSITIVE	24/01/13	Share
MEM	PrIME Completes lease for Singapore cGMP Facility		10/01/13	Share
MEM	Substantial Shareholder Notice		09/01/13	Share
MEM	Change in substantial holding		08/01/13	Share
MEM	PrIME completes first three trial production runs of Albumin	PRICE SENSITIVE	08/01/13	Share
MEM	NuSep receives Final Tranche payment and Appendix 3B		02/01/13	Share
MEM	NuSep Receives $1.54m R&D Tax Refund		17/12/12	Share
MEM	Response to ASX Letter re Disclaimer of Audit Opinion		13/12/12	Share
MEM	Change of Director's Interest Notice		11/12/12	Share
MEM	Amendment of 2012 AGM Poll numbers		11/12/12	Share
MEM	Change of Director's Interest Notice - Manusu, Nair, Goodall		06/12/12	Share
MEM	Appendix 3B		06/12/12	Share
MEM	Final Director's Interest Notices		04/12/12	Share
MEM	Update on PrIME Spin Out Resolution	PRICE SENSITIVE	04/12/12	Share
MEM	Initial Director's Interest Notice - P Patel and C Eu		04/12/12	Share
MEM	Results of Meeting		30/11/12	Share
MEM	Board Update	PRICE SENSITIVE	30/11/12	Share
MEM	Shareholder Update		30/11/12	Share
MEM	Board Changes		28/11/12	Share
MEM	Appendix 3B		22/11/12	Share
MEM	Prof John Aitken Awarded as NSW Scientist of the Year 2012		15/11/12	Share
MEM	NuSep achieves TGA accreditation for Diagnostics	PRICE SENSITIVE	12/11/12	Share
MEM	Becoming a substantial holder		02/11/12	Share
MEM	Cleansing Notice		02/11/12	Share
MEM	NuSep Annual Report 2012		31/10/12	Share
MEM	NuSep NOM 2012 AGM and EGM		30/10/12	Share
MEM	Appendix 3B		30/10/12	Share
MEM	NuSep Makes a 15% Placement	PRICE SENSITIVE	30/10/12	Share
MEM	NuSep Updated Board Charters		30/10/12	Share
MEM	Correction to Spin Out of PrIME Biologics And Update of Time		30/10/12	Share
MEM	NuSep clears shares held in suspense account		29/10/12	Share
MEM	NuSep 2012 AGM		15/10/12	Share
MEM	Spin Out of PrIME Biologics	PRICE SENSITIVE	15/10/12	Share
MEM	Critical Milestone with Installation of PrIME unit in Singap	PRICE SENSITIVE	03/10/12	Share
MEM	Substantial Shareholder Notice		02/10/12	Share
MEM	Annual Financial Report 30 June 2012		28/09/12	Share
MEM	NuSep Working Capital Advance and update on DCS Debt	PRICE SENSITIVE	27/09/12	Share
MEM	Research Report on NuSep		06/09/12	Share
MEM	NuSep announces 30 June 2012 Full Year Results	PRICE SENSITIVE	30/08/12	Share
MEM	Update on PrIME Developments and impact on 30.06.12 results	PRICE SENSITIVE	28/08/12	Share
MEM	Notice to holders of 35 cent options (NSPO)		21/08/12	Share

MEMAppendix 3Y and Form 604
30/12/13		Share
MEMPrIME receives Xeraya Board conditional approval for Funding
24/12/13	PRICE SENSITIVE	Share
MEMCompany Secretary Change
19/12/13		Share
MEMNuSep Board Appointment
02/12/13		Share
MEMNuSep Board Changes
29/11/13		Share
MEMNuSep Results of AGM
29/11/13		Share
MEMNuSep 2013 AGM Presentation
29/11/13		Share
MEMAppendix 3Y and Form 604
27/11/13		Share
MEMAnnual Report
31/10/13		Share
MEMNotice of Annual General Meeting as mailed to Shareholders
30/10/13		Share
MEMNotice of Annual General Meeting/Proxy Form
30/10/13		Share
MEMBoard Changes
29/10/13		Share
MEMPrIME signs Non Binding Funding Term Sheet
29/10/13	PRICE SENSITIVE	Share
MEMNuSep Receives $1.6m R&D Tax Refund
08/10/13	PRICE SENSITIVE	Share
MEMAnnual Financial Report 30 June 2013
01/10/13		Share
MEMAppendix 3B
16/09/13		Share
MEMNuSep Presents at Bioplasma Conference
06/09/13		Share
MEMChange in substantial holding x 2
30/08/13		Share
MEMNuSep announces 30 June 2013 Full Year Results
30/08/13	PRICE SENSITIVE	Share
MEMIncrease in Director Holdings
29/08/13		Share
MEMNuSep Restatement of Prior Period Accounts
29/08/13		Share
MEMNuSep Raises $1.2m under SPP
26/08/13		Share
MEMNuSep lodges $1.6m R&D Tax Refund
23/08/13	PRICE SENSITIVE	Share
MEMRelodgement of Initial Substantial Shareholder
21/08/13		Share
MEMBecoming a substantial holder
21/08/13		Share
MEMNuSep 2013 SPP Closes
20/08/13		Share
MEMUpdate on Settlement for the Acquisition of Singapore cGMP F
19/08/13		Share
MEMNuSep Investor Presentation - SPP
08/08/13		Share
MEMNuSep Shareholder Newsletter
07/08/13		Share
MEMNuSep SPP Update & Investor Meetings
02/08/13		Share
MEMUpdate on PrIME LOI Funding
29/07/13	PRICE SENSITIVE	Share
MEMNuSep Share Purchase Plan 2013
23/07/13		Share
MEMSection 708A SPP Cleansing Statement
23/07/13		Share
MEMFunding Update & SPP Announcement
22/07/13	PRICE SENSITIVE	Share
MEMInitial Substantial Shareholder
17/07/13		Share
MEMResearch Report on NuSep
10/07/13		Share
MEMNuSep Investor Presentation
10/07/13		Share
MEMNuSep Announces Long Term Debt Management
09/07/13	PRICE SENSITIVE	Share
MEMChange of Address & Registered Office
05/07/13		Share
MEMNuSep - New Headquarters
24/06/13		Share
MEMPrIME Receives Plasma Importation License
11/06/13	PRICE SENSITIVE	Share
MEMNuSep Signs LOI to Fund PrIME
03/06/13	PRICE SENSITIVE	Share
MEMCompany Secretary Update
03/06/13		Share
MEMFirst PrIME Franchise Proposal
30/05/13	PRICE SENSITIVE	Share
MEMDengue Diagnostic & Therapeutic - New Application of PrIME
23/05/13	PRICE SENSITIVE	Share
MEMNuSep Appoints KPMG as Company Auditor
21/05/13		Share
MEMNuSep Update
20/05/13	PRICE SENSITIVE	Share
MEMPrIME Update
15/05/13	PRICE SENSITIVE	Share
MEMNSP Cleansing Notice
08/05/13		Share
MEMResignation of Auditor
01/05/13		Share
MEMNuSep Singapore PrIME Fundraising and Appendix 3B
01/05/13	PRICE SENSITIVE	Share
MEMDivestiture of non-core ProteoIQ software
15/03/13		Share
MEMReinstatement to Official Quotation
01/03/13	PRICE SENSITIVE	Share
MEMNuSep Half Year Report & Accounts
01/03/13	PRICE SENSITIVE	Share
AEJ +PDF KFG MCH MEM HYD QST SAP YOWSuspension from Official Quotation
01/03/13	PRICE SENSITIVE	Share
MEMAppointment of New Company Secretary
15/02/13		Share
MEMUpdated NuSep Charters
25/01/13		Share
MEMCeasing to be a substantial holder
24/01/13		Share
MEMBecoming a substantial holder
24/01/13		Share
MEMNuSep divests non Core ProteoIQ software
24/01/13	PRICE SENSITIVE	Share
MEMPrIME Completes lease for Singapore cGMP Facility
10/01/13		Share
MEMSubstantial Shareholder Notice
09/01/13		Share
MEMChange in substantial holding
08/01/13		Share
MEMPrIME completes first three trial production runs of Albumin
08/01/13	PRICE SENSITIVE	Share
MEMNuSep receives Final Tranche payment and Appendix 3B
02/01/13		Share
MEMNuSep Receives $1.54m R&D Tax Refund
17/12/12		Share
MEMResponse to ASX Letter re Disclaimer of Audit Opinion
13/12/12		Share
MEMChange of Director's Interest Notice
11/12/12		Share
MEMAmendment of 2012 AGM Poll numbers
11/12/12		Share
MEMChange of Director's Interest Notice - Manusu, Nair, Goodall
06/12/12		Share
MEMAppendix 3B
06/12/12		Share
MEMFinal Director's Interest Notices
04/12/12		Share
MEMUpdate on PrIME Spin Out Resolution
04/12/12	PRICE SENSITIVE	Share
MEMInitial Director's Interest Notice - P Patel and C Eu
04/12/12		Share
MEMResults of Meeting
30/11/12		Share
MEMBoard Update
30/11/12	PRICE SENSITIVE	Share
MEMShareholder Update
30/11/12		Share
MEMBoard Changes
28/11/12		Share
MEMAppendix 3B
22/11/12		Share
MEMProf John Aitken Awarded as NSW Scientist of the Year 2012
15/11/12		Share
MEMNuSep achieves TGA accreditation for Diagnostics
12/11/12	PRICE SENSITIVE	Share
MEMBecoming a substantial holder
02/11/12		Share
MEMCleansing Notice
02/11/12		Share
MEMNuSep Annual Report 2012
31/10/12		Share
MEMNuSep NOM 2012 AGM and EGM
30/10/12		Share
MEMAppendix 3B
30/10/12		Share
MEMNuSep Makes a 15% Placement
30/10/12	PRICE SENSITIVE	Share
MEMNuSep Updated Board Charters
30/10/12		Share
MEMCorrection to Spin Out of PrIME Biologics And Update of Time
30/10/12		Share
MEMNuSep clears shares held in suspense account
29/10/12		Share
MEMNuSep 2012 AGM
15/10/12		Share
MEMSpin Out of PrIME Biologics
15/10/12	PRICE SENSITIVE	Share
MEMCritical Milestone with Installation of PrIME unit in Singap
03/10/12	PRICE SENSITIVE	Share
MEMSubstantial Shareholder Notice
02/10/12		Share
MEMAnnual Financial Report 30 June 2012
28/09/12		Share
MEMNuSep Working Capital Advance and update on DCS Debt
27/09/12	PRICE SENSITIVE	Share
MEMResearch Report on NuSep
06/09/12		Share
MEMNuSep announces 30 June 2012 Full Year Results
30/08/12	PRICE SENSITIVE	Share
MEMUpdate on PrIME Developments and impact on 30.06.12 results
28/08/12	PRICE SENSITIVE	Share
MEMNotice to holders of 35 cent options (NSPO)
21/08/12		Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 0.5¢		Change 0.000(0.00%)		Mkt cap ! $13.00M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.5¢	$935	187K

Buyers (Bids)

No.	Vol.	Price($)
6	5639600	0.5¢

Sellers (Offers)

Price($)	Vol.	No.
0.6¢	11066843	9

View Market Depth

No.	Vol.	Price($)
2	60206	0.024
1	14090	0.022
3	497619	0.021
5	649700	0.020
2	130000	0.018

Price($)	Vol.	No.
0.025	153799	6
0.037	18526	1
0.039	1200000	1
0.046	100000	1
0.047	1160000	3

Last trade - 11.48am 28/11/2024 (20 minute delay)

MEM (ASX) Chart